ArticleFrontiers in pharmacology2026
Gastrodin alleviates mild cognitive impairment and Alzheimer's disease via candidate targeting of ACHE, S1PR5, SERPINE1, and TOP2A: an integrative computational and cellular study.
Yu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.